These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3301895

  • 1. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M, Bitar RA, Bartlett JG.
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [Abstract] [Full Text] [Related]

  • 2. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
    Hörmeyer E, Schultz A, Sailer J, Opitz G, Stünkel K, Petzoldt K.
    Berl Munch Tierarztl Wochenschr; 1985 Jan 01; 98(1):16-9. PubMed ID: 3885940
    [No Abstract] [Full Text] [Related]

  • 3. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M, Bartlett JG.
    J Clin Microbiol; 1984 May 01; 19(5):645-8. PubMed ID: 6376538
    [Abstract] [Full Text] [Related]

  • 4. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
    Keller JE.
    Clin Vaccine Immunol; 2008 Sep 01; 15(9):1374-9. PubMed ID: 18667637
    [Abstract] [Full Text] [Related]

  • 5. Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.
    Held DM, Shurtleff AC, Fields S, Green C, Fong J, Jones RG, Sesardic D, Buelow R, Burke RL.
    Clin Vaccine Immunol; 2010 Jun 01; 17(6):930-6. PubMed ID: 20410329
    [Abstract] [Full Text] [Related]

  • 6. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J, Reiss J, Michalik M.
    Arch Immunol Ther Exp (Warsz); 1994 Jun 01; 42(2):129-33. PubMed ID: 7503646
    [Abstract] [Full Text] [Related]

  • 7. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M, Bartlett JG.
    Diagn Microbiol Infect Dis; 1991 Jun 01; 14(1):11-5. PubMed ID: 2013205
    [Abstract] [Full Text] [Related]

  • 8. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
    Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT, Friedlander AM, Sjogren MH.
    Vaccine; 2002 May 15; 20(16):2107-15. PubMed ID: 11972980
    [Abstract] [Full Text] [Related]

  • 9. Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.
    Doellgast GJ, Triscott MX, Beard GA, Bottoms JD.
    J Clin Microbiol; 1994 Mar 15; 32(3):851-3. PubMed ID: 8195408
    [Abstract] [Full Text] [Related]

  • 10. An improved method for development of toxoid vaccines and antitoxins.
    Jones RG, Liu Y, Rigsby P, Sesardic D.
    J Immunol Methods; 2008 Aug 20; 337(1):42-8. PubMed ID: 18571196
    [Abstract] [Full Text] [Related]

  • 11. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M, Bartlett JG.
    Diagn Microbiol Infect Dis; 1985 Mar 20; 3(2):105-12. PubMed ID: 3884243
    [Abstract] [Full Text] [Related]

  • 12. Clostridium botulinum subtype Ba.
    Giménez DF.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May 20; 257(1):68-72. PubMed ID: 6380157
    [Abstract] [Full Text] [Related]

  • 13. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL.
    Appl Environ Microbiol; 1976 Feb 20; 31(2):234-42. PubMed ID: 793522
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.
    Siegel LS.
    J Clin Microbiol; 1989 Aug 20; 27(8):1906-8. PubMed ID: 2768475
    [Abstract] [Full Text] [Related]

  • 15. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S, Dufrenne J, Kozaki S.
    Jpn J Med Sci Biol; 1982 Aug 20; 35(5-6):203-11. PubMed ID: 6761472
    [Abstract] [Full Text] [Related]

  • 16. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS, Duarte MC, Oliveira Junior CA, de Assis RA, Lana AMQ, Lobato FCF.
    Anaerobe; 2018 Dec 20; 54():19-22. PubMed ID: 30076896
    [Abstract] [Full Text] [Related]

  • 17. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON, Ciccarelli AS, Giménez DF.
    Rev Argent Microbiol; 1980 Dec 20; 12(1):10-7. PubMed ID: 6755549
    [Abstract] [Full Text] [Related]

  • 18. The antibody response of cattle to Clostridium botulinum types C and D toxoids.
    Jansen BC, Knoetze PC, Visser F.
    Onderstepoort J Vet Res; 1976 Dec 20; 43(4):165-73. PubMed ID: 799279
    [Abstract] [Full Text] [Related]

  • 19. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
    Mahmut N, Inoue K, Fujinaga Y, Arimitsu H, Sakaguchi Y, Hughes L, Hirst R, Murphy T, Tsuji T, Watanabe T, Ohyama T, Karasawa T, Nakamura S, Yokota K, Oguma K.
    J Med Microbiol; 2002 Oct 20; 51(10):813-820. PubMed ID: 12435059
    [Abstract] [Full Text] [Related]

  • 20. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay.
    Siegel LS.
    J Clin Microbiol; 1988 Nov 20; 26(11):2351-6. PubMed ID: 3235662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.